Researcher Guidance

Brief overview with key points for submitting an amendment application in IRBOnline.

This document includes a list of the questions from the Amendment Application in IRBOnline and includes commentary to assist with understanding what types of responses OPRS and IRB are requesting.

If UIUC faculty, staff, or students (including CI MED students) are required to submit an Exempt application to the Carle IRB, an application must also be submitted to UIUC via IRBOnline.  Use this table map what responses from the Carle application can be directly input into the IRBOnline New Study Application.  The table also includes other tips and recommendations to make the application process easier.

This document provides tips for transitioning an existing, active project to the IRBOnline system.  

Use this mapping table for existing applications submitted on the Protocol Form version 03/02/2022 to map the responses to the New Study Application in IRBOnline.  

The IRB reviews recruitment methods, including advertisements, to ensure that they do not interfere with the equitable selection of participants. The IRB reviews proposed advertisements and solicitations for research participation to ensure that they do not violate the regulatory requirements of consent.

Assent means a participant's affirmative agreement to participate in research.  Assent is used for children or adults with diminished decision-making capacity when the participant is unable to provide legal consent, which is provided by the parent or legally authorized representative.

Research defined as “Basic Physiological Research” is considered to fall outside of the IDE regulations and is therefore not defined within FDA regulation. Although the IDE regulations do not apply to this type of research, IRB approval and informed consent should be obtained prior to initiation of the study. 

Certificates of Confidentiality (CoCs) are intended to protect the privacy of research subjects by prohibiting disclosure of identifiable, sensitive information to anyone not connected to the research except when the subject consents, or in a few other specific situations. 

The IRB reviews payment arrangements to research participants (compensation) to ensure an equitable selection of subjects by only approving payment methods that are not coercive and do not present undue influence.  

The revised “common rule” (effective January 21, 2019) requires that key information be included in
the beginning of the informed consent in a concise and focused presentation. 

This pdf provides guidance for researchers and IRBs about special requirements for conducting and reviewing human subjects research involving any component of the Department of Defense (DoD).

Data Monitoring: The regular evaluation of data and documentation collected during a study to ensure both adhere to the approved investigative plan and the validity of data collected (White 2007).

Safety Monitoring: The observations required to minimize threats to the safety and welfare of research subjects (White
2007).

Exempt studies are minimal risk and fit within a set of established exemption categories. Exemption determinations are made by the IRB and may not be made by the individual investigator.

When exercise testing is used as part of a research study, investigators must provide the IRB with information regarding the safety plan. 

Research activities may be reviewed by the IRB through the expedited review procedure authorized by 45 CFR 46.110 and 21 CFR 56.110.

When researchers ask questions about sex, gender identity, and/or sexual orientation, there must be an understanding of what is being asked and what information is sought.

To protect patient privacy, “covered entities” (all health plans, health care “clearinghouses,” and health care providers) must obtain specific, written authorization from a patient to use or disclose PHI. Patients must also be notified about their right to restrict the use and disclosure of such information.

This checklist will assist investigators in determining if an IND is needed from the FDA in order to conduct a clinical trial using a drug or biologic.  The IRB may determine that an IND is not necessary based on the criteria below. However, the IRB may also require that the investigator request and exemption from the FDA, which requires the submission of an IND application.  

This guidance pertains to when the IRB requests letter of support from an authorized individual at proposed research site(s) as part of the review process. A letter of support indicates to the IRB that individuals who may be impacted by, or who have an interest in, the research are generally supportive of the project.

Using multimedia tools to record the image and/or voice of an individual creates a record that requires careful handling and storage, particularly if the content of media or the purpose of the research may be considered sensitive.

This document provides comments and suggestions to assist with completion of the New Study Application Form. Please be aware that all notes are inserted as "Comments" in the documents.

The IRB does not allow the use of finder’s fees or bonus payments made specifically to individuals, such as investigators and study staff, who are conducting the research. Exceptions must be reviewed by the IRB in order to determine that the use of such methods does not create coercion or undue influence.

This guidance provides information about IRB considerations for privacy and confidentiality in research.

Employees may be exposed to a greater risk of invasion of privacy than other research participants who have no association with the sponsoring institution. 

The IRB reviews the process of screening, recruiting, and determining eligibility. The IRB reviews proposed recruitment procedures and advertisements to ensure that they do not violate the regulatory requirements of consent.

Students attending an institution of higher learning are not directly mentioned in the federal regulations as a vulnerable population.  However, the University of Illinois Urbana-Champaign IRB considers students of the research institution to be a vulnerable population because students may be vulnerable to coercion or undue influence. 

It is the obligation of the IRB to consider the study design and overall quality of a study in order to effectively evaluate the risk-benefit ratio. If the IRB cannot determine that the risk-benefit ratio of a study is acceptable, it cannot approve the protocol under applicable ethical codes and regulations.  

The IRB must consider the general criteria for IRB approval for all studies, including those that involve children.  Federal regulations require additional safeguards when approving research involving children.